NCT05293717View on ClinicalTrials.gov

Topical Ruxolitinib in Chronic Hand Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

July 11, 2022

Primary Completion Date

June 21, 2023

Study Completion Date

December 31, 2024

Conditions

Chronic Hand Dermatitis

Interventions

DRUG

Ruxolitinib

1.5% Ruxolitinib cream

Trial Locations (1)

14642

UR Medicine Dermatology College Town, Rochester

Sponsors

Collaborators (1)

Incyte Corporation

All Listed Sponsors

collaborator

Incyte Corporation

INDUSTRY

lead

University of Rochester

OTHER

NCT05293717 - Topical Ruxolitinib in Chronic Hand Dermatitis | Biotech Hunter | Biotech Hunter